Please assess the completion status of the following clinical trial:

Trial Title: Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Clinical diagnosis of CD55-deficient PLE/CHAPLE disease (based on a history of PLE), confirmed by biallelic CD55 loss-of-function mutation detected by genotype analysis~* Active disease as defined by the protocol or inactive disease on eculizumab therapy (and whose treating physician has the expectation of future access to renewed eculizumab treatment should this be required), and is willing to discontinue eculizumab during screening and start pozelimab at baseline with no eculizumab wash-out~Key Exclusion Criteria:~* History of meningococcal infection~* No documented meningococcal vaccination within 3 years prior to screening and patient unwilling to undergo vaccination during the study~* No documented vaccination for Haemophilus influenzae and Streptococcus pneumoniae if applicable based on local practice or guidelines prior to screening and patient unwilling to undergo vaccination during the study if required per local practice or guidelines~* Presence of a concomitant disease that leads to hypoproteinemia at the time of starting pozelimab~* A concomitant disease that leads to secondary intestinal lymphangiectasia such as a fontan procedure for congenital heart disease~Note: Other protocol-defined Inclusion/Exclusion criteria apply.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active PLE (Type: EXPERIMENTAL): Patients aged 1 year and older with a clinical diagnosis of CD55-deficient PLE disease

Based on this trial design, predict the completion outcome and termination type (if applicable).